BB Biotech — Continuing to outperform the benchmark
BB Biotech (BION) delivered strong 2025 results, with NAV increasing 26.5% (in Swiss franc terms), comfortably outperforming BION’s benchmark, the...
117 Views
BB Biotech — Turning milestones into momentum
BB Biotech (BION) delivered strong Q325 results, underpinned by its focus on innovative biotech companies with differentiated clinical pipelines...
248 Views
BB Biotech — Optimistic about biotech’s long-term prospects
During 2024 and early this year, the biotech sector began to show signs of a structural recovery, supported by positive clinical data, regulatory...
349 Views
BB Biotech - A key milestone with significance for the sector
BB Biotech (BION) invests in innovative, rapidly expanding biotech companies. BION’s portfolio company Wave Life Sciences (Wave) recently announced...
307 Views
BB Biotech - Lower rates and news flow to support recovery
BB Biotech (BION) offers investors exposure to the innovative, rapidly expanding biotech sector. It is the largest biotech investor among its...
314 Views